Real-time enrollment status for this intestinal neoplasms clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:07 PM UTC
| NCT Number | NCT07222800 |
| Recruiting Status | Recruiting |
| Condition | Intestinal Neoplasms |
| Phase | PHASE3 |
| Target Enrollment | 800 participants |
| Active Locations | 254 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | October 8, 2026 (1 week ago) |
As of October 21, 2026: Clinical trial NCT07222800 is currently recruiting participants. This phase3 study for intestinal neoplasms is actively seeking new participants at 254 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07222800 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 254 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07222800 was last updated 1 week ago (October 8, 2026). HelloStudys verifies this status automatically.